However, other studies concluded that GDF11 was associated with comorbidity, frailty, and post-operative outcomes in cardiovascular disease and that GDF11 supplementation did not rescue aging-related pathological hypertrophy [5, 84, 85]. Here, GDF11 is linked to cardiovascular disorder.